BALTIMORE, Md. — CoapTech, a medical technology company focused on advancing ultrasound-guided solutions for enteral access, has named Brad Kreger as its new Chief Executive Officer. Co-Founder and outgoing CEO Howard Carolan is stepping down and will remain as an advisor to support a smooth leadership transition.
“We are excited to welcome Brad as our next CEO. Brad’s background in medical device manufacturing, and his track record of scaling organizations makes him uniquely suited to accelerate CoapTech’s growth and lead the company to its next stage,” said Bill Walker, Ph.D., Chairman of the Board at CoapTech. “On behalf of the Board, I want to extend our deepest gratitude to Howard for his vision, grit, and unwavering commitment to patients. Guiding CoapTech from a founding concept to a commercial organization that improves outcomes for patients is a major achievement.”
Prior to joining CoapTech, Kreger served as CEO of Velo3D, where he oversaw a major shift in the company’s go-to-market strategy and the commercialization of rapidly growing service offerings. He previously held senior leadership roles including Senior Vice President of Global Operations at Fluidigm Corporation, as well as key positions at Thermo Fisher Scientific and Affymetrix Inc.
“I am honored to continue building from the incredible foundation that Howard has created,” said Kreger. “I look forward to working with our amazing team to expand access to our percutaneous ultrasound gastrostomy technology, accelerate adoption across care settings, and deepen its impact on patients and healthcare providers.”
Carolan co-founded CoapTech and led the company from its inception to commercial status, pioneering innovative approaches to enteral access and positioning the company to scale its clinical and market influence.
